Drug Safety Testing Center (DSC)

The Drug Safety Testing Center (DSC) operates as a specialized entity focused on drug safety testing, functioning under the oversight of the Hong Kong Science and Technology Parks Corporation (HKSTP). Its headquarters are located in China, aligning with its administrative structure within the broader HKSTP framework. The available information does not detail the specific scope of its testing services, the full scale of its operations, or the particular markets and clients it serves beyond the noted incident involving employees and customers. Its core identity is derived from its designated function as a safety testing center, though quantitative measures of its capacity or reach are not provided in the source material.

In May 2025, DSC experienced a significant ransomware attack on its independent computer system, resulting in the compromise of personal data belonging to approximately thirty employees and twenty customers. The organization's immediate response included isolating affected servers, activating an internal incident task force, and reporting the crime to law enforcement authorities. DSC subsequently notified relevant government bodies and the privacy commissioner, actions that reflect established protocols for regulatory compliance and data breach disclosure. HKSTP, as the overseeing corporation, has been cooperating with the ongoing investigation and has commissioned an independent cybersecurity expert to conduct a thorough review and produce a formal report on the incident. The public was also warned to remain vigilant against suspicious communications falsely attributed to DSC, a measure aimed at mitigating secondary risks from the breach. This incident and the coordinated response underscore DSC's operational context within a larger corporate structure that mandates specific security and reporting procedures.